Search Results

You are looking at 31 - 40 of 127 items for :

  • "genetic counseling" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Rachel Hae-Soo Joung, Brianna Marie D'Orazio, Jeana Springmann, Julie Johnson, Karl Y. Bilimoria, and Anthony D. Yang

-based genetic counseling referrals for breast cancer patients. An oncology-focused adaptation of the QI Knowledge Application Tool (QI-KAT), a validated QI assessment, was administered pre- and post-intervention. Three educators scored each de-identified exam

Full access

Suzanne M. Mahon

visit with a genetics professional takes time (84 minutes 2 to 105 minutes 1 ); an average follow-up visit lasts 74 minutes. 2 Finding ways to efficiently provi genetic counseling services is critical in light of the limited numbers of credentialed

Full access

Filipa Lynce and Claudine Isaacs

results; the ability of the current model of genetic counseling practices to deal with the increase in patient volume; and the cost-effectiveness of such an approach. 8 , 9 One way of minimizing the identification of VUS, the impact of false

Full access

Margaret Tempero

reducing lifestyle risks that they can actually control? Considering the expanding need, the workforce shortage in genetic counseling is increasing to epic proportions, and I don't think there is a solution in sight. So I guess this is another call to

Full access

Julia R. Trosman, Christine B. Weldon, Michael P. Douglas, Allison W. Kurian, R. Kate Kelley, Patricia A. Deverka, and Kathryn A. Phillips

despite informed consent and genetic counseling, patients may not understand the immature state of evidence about numerous genes within panels (73%) and that their data are used for research, to which many would object if better informed. Payers' suspicion

Full access

Maxim Ivanov, Margarita Sharova, Andrea Olsen, Alexandra Lebedeva, Ekaterina Ignatova, Gerald Mouse, and Vladislav Mileyko

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 1 provide substantial groundwork for specialist practice in diverse fields: medical oncology, genetic

Full access

Sean Dineen, Patrick M. Lynch, Miguel A. Rodriguez-Bigas, Sarah Bannon, Melissa Taggart, Colleen Reeves, Cathy Modaro, Michael Overman, George J. Chang, John M. Skibber, and Y. Nancy You

chemotherapy regimens. 20 However, in practice, adherence to this guideline is poor, 21 , 22 and many patients are not referred for genetic counseling and workup. 23 We hypothesized that system-based practice intervention, designed with the Six Sigma quality

Full access

Lynn A. McCain, Kara J. Milliron, Amanda M. Cook, Robert Paquette, Jasmine B. Parvaz, Susan D. Ernst, Anne L. Kittendorf, Diane M. Harper, Philip Zazove, Jim Arthurs, Jerry A. Tippie, Bailey Hulswit, Lee F. Schroeder, David F. Keren, and Sofia D. Merajver

genetic counseling. In an integrated health system, 6 <30% of patients had family history documented in the medical record. As a result, there is a pressing need to improve genetics clinics’ efficiency, given the increasing number of patients being

Full access

Mary B. Daly, Robert Pilarski, Matthew B. Yurgelun, Michael P. Berry, Saundra S. Buys, Patricia Dickson, Susan M. Domchek, Ahmed Elkhanany, Susan Friedman, Judy E. Garber, Michael Goggins, Mollie L. Hutton, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison W. Kurian, Christine Laronga, Jennifer K. Litton, Julie S. Mak, Carolyn S. Menendez, Sofia D. Merajver, Barbara S. Norquist, Kenneth Offit, Tuya Pal, Holly J. Pederson, Gwen Reiser, Kristen Mahoney Shannon, Kala Visvanathan, Jeffrey N. Weitzel, Myra J. Wick, Kari B. Wisinski, Mary A. Dwyer, and Susan D. Darlow

Jewish ancestry, 1 , 2 , 4 , 5 providing some evidence to support population-based genetic testing among the Ashkenazi Jewish population. However, the panel raised concerns about the demand on genetic counseling resources, the preparedness of healthcare

Full access

Ying L. Liu and Zsofia K. Stadler

, microsatellite instability. The advantage of a tumor-only approach is efficiency, because germline DNA is not directly interrogated, and the necessary informed consents, privacy protections, and pretesting/posttesting genetic counseling inherent to traditional